BIOCRYST PHARMACEUTICALS INC Annual Income Tax Expense (Benefit) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
  • Biocryst Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $586K, a 77.6% increase year-over-year.
  • Biocryst Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$308K, a 117% decline year-over-year.
  • Biocryst Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $310K, a 88.7% decline from 2022.
  • Biocryst Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $2.73M, a 21.3% increase from 2021.
  • Biocryst Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $2.25M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $310K -$2.42M -88.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $2.73M +$480K +21.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $2.25M +$2.25M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $0 -$17.3M -100% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $17.3M +$8.75M +102% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-02
2013 $8.57M +$1.57M +22.4% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-02
2012 $7M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.